CROSSJECT revenue breakdown overview

CROSSJECT revenue for the last year amounted to 6.71 M EUR, the most of which — 145.00 k EUR — came from its highest performing source at the moment, Needle-free Injection System, the year earlier bringing 954.00 k EUR. The greatest contribution to the revenue figure was made by France — last year it brought CROSSJECT 145.00 k EUR, and the year before that — 954.00 k EUR.